Conference on Retroviruses and Opportunistic Infections (CROI)

Healio brings you the highlights from the Conference on Retroviruses and Opportunistic Infections (CROI). Refer back to this page often for the latest news from CROI, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News Coverage

Five lessons from CROI 2015

March 14, 2015
The value of pre-exposure prophylaxis, or PrEP, in HIV-negative individuals at risk for infection was one of the hottest topics at CROI 2015…
In the JournalsPerspective

Ebola outbreak leaves West Africa more susceptible to measles

March 12, 2015
Disruptions in local health care services in countries heavily affected by the Ebola crisis have led to significant decreases in childhood…
Meeting News Coverage

ION-4 Study: Harvoni yields high SVR in HIV/HCV-coinfected patients

March 11, 2015
SEATTLE — A treatment regimen of Harvoni for 12 weeks was safe and effective in treating patients coinfected with hepatitis C virus infection…
Meeting News Coverage

Expanded PrEP use in San Francisco could reduce infection rate

March 9, 2015
SEATTLE — A model predicting HIV transmission in San Francisco with expanded use of pre-exposure prophylaxis suggests that the number of new…
Meeting News Coverage

iPrEx investigators identify predictors of PrEP adherence

March 6, 2015
SEATTLE — Results from the iPrEx open-label extension trial show several key patient characteristics that predicted engagement with…
Meeting News Coverage

Smoking, atherosclerosis common among MSM with HIV

March 6, 2015
SEATTLE — Smoking rates appeared high among men who have sex with men with HIV and were associated with subclinical coronary atherosclerosis…
Meeting News Coverage

PrEP as bridge to ART highly successful in HIV prevention

March 3, 2015
SEATTLE — A project integrating time-limited pre-exposure prophylaxis along with ART among high-risk, serodiscordant couples demonstrated an…
Meeting News Coverage

HIV testing in ED serves as link to care

March 3, 2015
SEATTLE — An HIV testing program in an ED, which was originally implemented to describe the local epidemic, played a significant role in…
Meeting News Coverage

Survival benefit of 9.2 million life-years attributed to Brazilian ART program

March 2, 2015
SEATTLE — Universal ART offered in Brazil from 1997 to 2014 is estimated to have a population survival benefit of 9.2 million life-years, according…
Meeting News Coverage

Average cost per SVR12 was $171,000 for Olysio, Sovaldi regimens

March 2, 2015
SEATTLE — The mean cost per sustained virologic response at 12 weeks among a cohort of patients with hepatitis C virus infection receiving…